The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

How can immunotherapy be used in MDS?

During the European School of Haematology (ESH) 2nd Translational Research Conference: Erythropoiesis Control and Ineffective Erythropoiesis - From Bench to Bedside, the MDS Hub spoke to Rafael Bejar, UC San Diego, San Diego, US. We asked, How can immunotherapy be used in MDS?

How can immunotherapy be used in MDS?

In this video, Bejar discusses new promising immunotherapy agents for MDS, including immune checkpoint inhibitors, magrolimab, vaccines against MDS-like cells, and genetically modified T cells.

 

Share: